Establishment of humanised xenograft models as in vivo study for lung metastasis of osteosarcoma

被引:1
作者
Khamarudin, Farhana [1 ,2 ]
Muhamad, Mudiana
Ibahim, Mohamad Johari
Zain, Wan Nor I'zzah Wan Mohamad
Aziz, Mardiana Abdul [3 ]
Ridzuan, Nurul Raudzah Adib
Ab-Rahim, Sharaniza [1 ,4 ]
机构
[1] Univ Teknol MARA, Dept Biochem & Mol Med, Sungai Buloh 47000, Selangor, Malaysia
[2] Univ Teknol MARA, Inst Med Mol Biotechnol, Sungai Buloh 47000, Selangor, Malaysia
[3] Univ Teknol MARA, Dept Pathol, Sungai Buloh 47000, Selangor, Malaysia
[4] Univ Teknol MARA, Fac Med, Dept Biochem & Mol Med, Sungai Buloh Campus,Jalan Hosp, Sungai Buloh 47000, Selangor, Malaysia
来源
IMMUNOTHERAPY ADVANCES | 2024年 / 4卷 / 01期
关键词
xenograft; osteosarcoma; lung metastasis; mouse model; PULMONARY METASTASIS; PROGNOSTIC-FACTORS; SARCOMA;
D O I
10.1093/immadv/ltae002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Humanised xenograft models and cancer cell lines are widely used for preclinical drug evaluation, biological studies, and targeted therapy strategies in cancer research. A humanised mouse model is a laboratory mouse that has been genetically modified to contain specific human genes, cells, or tissues. By introducing human-specific elements into rodents, researchers can create a more accurate representation of human physiological and pathological processes. Lacking an appropriate animal model for osteosarcoma (OS), hindered understanding of underlying mechanisms in OS metastasis progression. Markedly, metastasis influences the prognosis and treatment of osteosarcoma. Gaining insight into the mechanisms and occurrences of metastasis could potentially facilitate oncologists in improving therapies. Hence, it is important to develop a lung metastatic OS model to study the basic biology of its progression. This study has established a tumour-bearing mouse model using HOS-143B cell line which was injected into male NOD.SCID gamma (NSG) mice at two locations; intramuscularly (hind leg) and subcutaneously (back) respectively. The primary and metastatic tumour size was monitored by palpating the area of tumour induced and quantified using digital calliper. H&E staining was performed by pathologist to confirm metastasis. Our results showed that mice injected with 1 million cancer cells were unable to produce tumours. Meanwhile, mice injected with three million cancer cells showed tumour development and lung metastasis after 25 days of cancer cell inoculation. In conclusion, this study has successfully established a lung metastatic OS mouse model that could be useful for biological studies of OS. These findings imply that this model is essential for safety and efficacy before clinical trials, accelerate the translation from basic research to therapeutic applications. Graphical Abstract
引用
收藏
页数:9
相关论文
共 29 条
  • [1] Ara Z., 2022, Acta Sci Cancer Biol, V6, P221
  • [2] A SEVERE COMBINED IMMUNODEFICIENCY MUTATION IN THE MOUSE
    BOSMA, GC
    CUSTER, RP
    BOSMA, MJ
    [J]. NATURE, 1983, 301 (5900) : 527 - 530
  • [3] Modeling Tumor Immunology and Immunotherapy in Mice
    Buque, Aitziber
    Galluzzi, Lorenzo
    [J]. TRENDS IN CANCER, 2018, 4 (09): : 599 - 601
  • [4] Preclinical models in head and neck squamous cell carcinoma
    Chaves, Patricia
    Garrido, Maria
    Oliver, Javier
    Perez-Ruiz, Elisabeth
    Barragan, Isabel
    Rueda-Dominguez, Antonio
    [J]. BRITISH JOURNAL OF CANCER, 2023, 128 (10) : 1819 - 1827
  • [5] miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo
    Chen, Cheng-long
    Zhang, Long
    Jiao, Yu-rui
    Zhou, Yi
    Ge, Qiao-feng
    Li, Peng-cui
    Sun, Xiao-juan
    Lv, Zhi
    [J]. FEBS LETTERS, 2019, 593 (10) : 1089 - 1101
  • [6] Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application
    Ciucci, Alessandra
    Buttarelli, Marianna
    Fagotti, Anna
    Scambia, Giovanni
    Gallo, Daniela
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (07)
  • [7] Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
    Fan, Tengjiao
    Sun, Guohui
    Sun, Xiaodong
    Zhao, Lijiao
    Zhong, Rugang
    Peng, Yongzhen
    [J]. CANCERS, 2019, 11 (03)
  • [8] Targeting the MAPK7/MMP9 axis for metastasis in primary bone cancer
    Green, Darrell
    Eyre, Heather
    Singh, Archana
    Taylor, Jessica T.
    Chu, Jason
    Jeys, Lee
    Sumathi, Vaiyapuri
    Coonar, Aman
    Rassl, Doris
    Babur, Muhammad
    Forster, Duncan
    Alzabin, Saba
    Ponthan, Frida
    McMahon, Adam
    Bigger, Brian
    Reekie, Tristan
    Kassiou, Michael
    Williams, Kaye
    Dalmay, Tamas
    Fraser, William D.
    Finegan, Katherine G.
    [J]. ONCOGENE, 2020, 39 (33) : 5553 - 5569
  • [9] Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
    Grignani, Giovanni
    Palmerini, Emanuela
    Ferraresi, Virginia
    D'Ambrosio, Lorenzo
    Bertulli, Rossella
    Asaftei, Sebastian Dorin
    Tamburini, Angela
    Pignochino, Ymera
    Sangiolo, Dario
    Marchesi, Emanuela
    Capozzi, Federica
    Biagini, Roberto
    Gambarotti, Marco
    Fagioli, Franca
    Casali, Paolo Giovanni
    Picci, Piero
    Ferrari, Stefano
    Aglietta, Massimo
    [J]. LANCET ONCOLOGY, 2015, 16 (01) : 98 - 107
  • [10] Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study
    Huang Xiaoyi
    Zhao Jian
    Bai Jinyi
    Shen Hua
    Zhang Bingbing
    Deng, Lulu
    Sun Chen
    Liu Yanfang
    Zhang Jing
    Zheng Jianming
    [J]. JOURNAL OF BONE ONCOLOGY, 2019, 16